New Drug Applications Archive - February 2014
Get news by email or subscribe to our news feeds.
February 6, 2014
February 7, 2014
February 10, 2014
February 11, 2014
- Melinta Therapeutics Raises $70 Million to Support Delafloxacin NDA and Selection of Multi-Drug Resistant Gram-Negative Candidates from RX-04 Platform
- Sprout Pharmaceuticals Receives Clear Guidance from FDA on Path Forward to Resubmit NDA for Flibanserin
February 12, 2014
February 14, 2014
- Nicox to re-focus Naproxcinod on Duchenne Muscular Dystrophy
- Chelsea Therapeutics Issues Statement Regarding Postponement of Northera NDA PDUFA Date
February 15, 2014
February 20, 2014
February 24, 2014
February 25, 2014
- BioCryst Announces Peramivir NDA Acceptance by the FDA
- InterMune Reports Phase 3 ASCEND Trial Results of Pirfenidone in Idiopathic Pulmonary Fibrosis (IPF)
